Ev » Tüm » Hisse Tahmini » Telomir Pharmaceuticals Inc. Common Stock Tahmin etmek

Telomir Pharmaceuticals Inc. Common Stock Tahmin etmek: Yarın, Hafta, Ay, 5 Yıl

Güncellendi: April 22 · 2026 at 07:03 UTC

From

▼ -6.08%Market Cap $47.79M · Technical analysis Bearish · Focus area Price + volatility

Tahmin Özeti

Zaman aralığı	Tahmini Fiyat	Geçmiş	Tarihsel	İç yüzü
Yarın	$1.41 ▲ +1.77%	Dün	$1.38 ▼ -0.74%	Tomorrow's Telomir Pharmaceuticals Inc. Common Stock (TELO) setup is anchored to $1.39 and targets $1.41 (+1.77%). The near-term read is upside; watch $1.43 / $1.35 because daily realized volatility is about 8.00%.
Tomorrow's Telomir Pharmaceuticals Inc. Common Stock (TELO) setup is anchored to $1.39 and targets $1.41 (+1.77%). The near-term read is upside; watch $1.43 / $1.35 because daily realized volatility is about 8.00%.
Hafta	$1.47 ▲ +5.50%	Geçen hafta	$1.36 ▼ -2.31%	The 7-day Telomir Pharmaceuticals Inc. Common Stock model moves from $1.36 to $1.47 (+5.50%). It gives upside momentum context for this stock, so breaks around $1.43 / $1.35 matter more than a single tick.
The 7-day Telomir Pharmaceuticals Inc. Common Stock model moves from $1.36 to $1.47 (+5.50%). It gives upside momentum context for this stock, so breaks around $1.43 / $1.35 matter more than a single tick.
Ay	$1.55 ▲ +11.71%	Geçen ay	$1.32 ▼ -4.92%	The 1-month Telomir Pharmaceuticals Inc. Common Stock target is $1.55 (+11.71%), compared with the live reference near $1.39. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk.
The 1-month Telomir Pharmaceuticals Inc. Common Stock target is $1.55 (+11.71%), compared with the live reference near $1.39. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk.
Yıl	$1.68 ▲ +21.03%	Geçen sene	$1.27 ▼ -8.83%	The 1-year Telomir Pharmaceuticals Inc. Common Stock scenario points to $1.68 (+21.03%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates.
The 1-year Telomir Pharmaceuticals Inc. Common Stock scenario points to $1.68 (+21.03%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates.
5 Yıl	$1.99 ▲ +42.86%	5 Yıl Önce	$1.14 ▼ -18.00%	The 5-year Telomir Pharmaceuticals Inc. Common Stock view is $1.99 (+42.86%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path.
The 5-year Telomir Pharmaceuticals Inc. Common Stock view is $1.99 (+42.86%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path.

Yarın$1.41▲ +1.77%

Dün$1.38▼ -0.74%

Tomorrow's Telomir Pharmaceuticals Inc. Common Stock (TELO) setup is anchored to $1.39 and targets $1.41 (+1.77%). The near-term read is upside; watch $1.43 / $1.35 because daily realized volatility is about 8.00%.

Hafta$1.47▲ +5.50%

Geçen hafta$1.36▼ -2.31%

The 7-day Telomir Pharmaceuticals Inc. Common Stock model moves from $1.36 to $1.47 (+5.50%). It gives upside momentum context for this stock, so breaks around $1.43 / $1.35 matter more than a single tick.

Ay$1.55▲ +11.71%

Geçen ay$1.32▼ -4.92%

The 1-month Telomir Pharmaceuticals Inc. Common Stock target is $1.55 (+11.71%), compared with the live reference near $1.39. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk.

Yıl$1.68▲ +21.03%

Geçen sene$1.27▼ -8.83%

The 1-year Telomir Pharmaceuticals Inc. Common Stock scenario points to $1.68 (+21.03%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates.

5 Yıl$1.99▲ +42.86%

5 Yıl Önce$1.14▼ -18.00%

The 5-year Telomir Pharmaceuticals Inc. Common Stock view is $1.99 (+42.86%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path.

Risk notice:This forecast is informational only, not financial advice; accuracy depends on volatility, liquidity, macro events, and other external factors.

Fiyat Tablosu

TarihselTahmin etmekYükselişdüşüş eğilimi

Teknik Analiz

Neutral

Yükseliş

Doğal

düşüş eğilimi

Temel Göstergeler

Gösterge	Değer	Sinyal
Price	$1.39	Mid
Daily Change	-6.08%	Below
Volatility Cap	20.0%	Mid
Confidence	70%	Above
Data Source	nasdaq-screener	Mid

Geçmiş Veriler

Current$1.39

Daily Change-6.08%

Market Cap$47.79M

Sourcenasdaq-screener

Current	$1.39	Daily Change	-6.08%
Market Cap	$47.79M	Source	nasdaq-screener

Destek ve Direnç Seviyeleri

$1.35Support 1

$1.39Akım

$1.43Resistance 1

shield

Support and resistance are estimated from the trusted current price until deeper historical data is available.

Fiyat Aşamaları

Anahtar seviyeler ve tarihsel bağlam

Current$1.39Live reference price

Used as the anchor for generated forecast calculations.

Next Month$1.55Model projection+11.71%

Directional scenario based on capped drift.

Tahmin Doğruluğu

Modelimizin performansı nasıl?

70%

Yönlü

Generated market-data forecast

This page uses live catalog market data and conservative volatility caps. It is informational, not financial advice.

📊

Algoritmamız, en son fiyat hareketi, oynaklık rejimi ve gösterge sinyalleri kullanılarak haftalık olarak yeniden kalibre edilir. Doğruluk zaman dilimine göre değişir; kısa vadeli momentum, uzun vadeli tahminlerden daha güvenilirdir.

Short term

70%

Direction confidence

Long term

Lower

Forecast uncertainty rises with horizon

Yatırım Senaryoları

Bugün $1,000'yu TELO'ya yatırırsanız

Bullish Scenario

$1.46

+5.00% from current

Hedef Fiyat$1.46

SenaryoUpside momentum

Olasılık62%

Base Scenario

$1.55

+11.71%

Hedef Fiyat$1.55

SenaryoCapped drift

Olasılık70%

Bearish Scenario

$1.32

-5.00% from current

Hedef Fiyat$1.32

SenaryoVolatility drawdown

Olasılık30%

Temel: Scenario model combines current spot price, recent market direction, and conservative asset-class volatility caps.

Tahmin Faktörleri

Market Structure

Price structure reflects the latest momentum regime and support/resistance interaction.

Momentum Bullish · 75/100

24H drift+1.77%

7D drift+5.50%

30D drift+11.71%

Technical Signals

Signals combine RSI, MACD, and moving average stacks to estimate short-term direction.

Mixed — Watching · 50/100

RSIn/a

MACDn/a

MA stackn/a

Macro Context

Rates, dollar strength, and cross-asset risk appetite influence medium-term paths.

Risk-On Tentative · 71/100

1M outlook+11.71%

1Y outlook+21.03%

5Y outlook+42.86%

Sıkça Sorulan Sorular

Q What is the Telomir Pharmaceuticals Inc. Common Stock (TELO) forecast for tomorrow?

Using the latest BeCoin market snapshot (April 22 · 2026 at 07:03 UTC), Telomir Pharmaceuticals Inc. Common Stock is projected near $1.41 versus the current reference around $1.39. That implies a modeled move of +1.77% over the next day, with realized prices still sensitive to intraday volatility.

Q What does the 7-day stock outlook suggest for TELO?

The weekly Telomir Pharmaceuticals Inc. Common Stock model points to $1.47, which maps to an expected drift of +5.50% from current conditions. This horizon reacts quickly to momentum shifts, so support/resistance breaks can change the path faster than long-term targets.

Q How should I read the Telomir Pharmaceuticals Inc. Common Stock 1-month and 1-year targets?

The Telomir Pharmaceuticals Inc. Common Stock 1-month target is $1.55 (+11.71%), while the 1-year target is $1.68 (+21.03%). The monthly view tracks prevailing trend pressure, and the yearly view reflects broader cycle assumptions shaped by price momentum, liquidity, and company-specific risk.

Q Why does the Telomir Pharmaceuticals Inc. Common Stock 5-year scenario differ from short-term rows?

The Telomir Pharmaceuticals Inc. Common Stock long-horizon scenario sits near $1.99 with a modeled change of +42.86%. It compounds cycle-continuation assumptions over time, so it should be treated as a scenario envelope rather than a precise endpoint.

Q Where are TELO support and resistance zones right now?

For Telomir Pharmaceuticals Inc. Common Stock, nearest resistance is around $1.35, while nearest support is around $1.43. A clean break above resistance improves continuation odds, while repeated closes under support raise downside risk.

Q How fresh is the Telomir Pharmaceuticals Inc. Common Stock market snapshot?

The displayed stock snapshot is labeled April 22 · 2026 at 07:03 UTC; the latest observed session range is roughly n/a to n/a. These checkpoints are rebuilt from the market feed so the FAQ, milestones, and support/resistance context stay tied to the same data refresh.